BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32880626)

  • 21. Analysis of treatment results for floor-of-mouth cancer.
    Sessions DG; Spector GJ; Lenox J; Parriott S; Haughey B; Chao C; Marks J; Perez C
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1764-72. PubMed ID: 11037841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial.
    Beaver K; Tysver-Robinson D; Campbell M; Twomey M; Williamson S; Hindley A; Susnerwala S; Dunn G; Luker K
    BMJ; 2009 Jan; 338():a3147. PubMed ID: 19147478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
    Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group.
    Goldberg RM; Fleming TR; Tangen CM; Moertel CG; Macdonald JS; Haller DG; Laurie JA
    Ann Intern Med; 1998 Jul; 129(1):27-35. PubMed ID: 9652996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
    Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D;
    JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA.
    Pagh A; Vedtofte T; Lynggaard CD; Rubek N; Lonka M; Johansen J; Andersen E; Kristensen CA; von Buchwald C; Andersen M; Godballe C; Overgaard J; Grau C
    Acta Oncol; 2013 Feb; 52(2):277-84. PubMed ID: 23320772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Fakhry C; Blackford AL; Neuner G; Xiao W; Jiang B; Agrawal A; Gillison ML
    JAMA Oncol; 2019 Jul; 5(7):985-992. PubMed ID: 31046104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Quality of Life With Surgical Excision of Early-Stage Melanoma of the Head and Neck.
    Mori S; Blank NR; Connolly KL; Dusza SW; Nehal KS; Rossi AM; Lee EH
    JAMA Dermatol; 2019 Jan; 155(1):85-89. PubMed ID: 30422228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is routine holistic assessment with a prompt list feasible during consultations after treatment for oral cancer?
    Rogers SN; Ahiaku S; Lowe D
    Br J Oral Maxillofac Surg; 2018 Jan; 56(1):24-28. PubMed ID: 29174806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
    Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
    JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes.
    Lim AW; Mesher D; Gentry-Maharaj A; Balogun N; Jacobs I; Menon U; Sasieni P
    J Natl Cancer Inst; 2012 Jan; 104(2):114-24. PubMed ID: 22247022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
    Abgral R; Querellou S; Potard G; Le Roux PY; Le Duc-Pennec A; Marianovski R; Pradier O; Bizais Y; Kraeber-Bodéré F; Salaun PY
    J Nucl Med; 2009 Jan; 50(1):24-9. PubMed ID: 19091901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
    Krabbe CA; Pruim J; Dijkstra PU; Balink H; van der Laan BF; de Visscher JG; Roodenburg JL
    J Nucl Med; 2009 Dec; 50(12):1940-7. PubMed ID: 19910434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shared care follow-up of patients with B-cell neoplasms based on nurse-led telephone consultations and PRO-data: a feasibility study from the North Denmark Region.
    Sommer M; Frandsen L; Jensen P; Nielsen SR; Nielsen LB; Brøndum RF; Bøgsted M; Madsen J; Severinsen MT; Sørensen EE; Grønkjær M; El-Galaly TC
    BMC Health Serv Res; 2020 Nov; 20(1):1047. PubMed ID: 33198756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the quality of life of the patients with treated oral cancer in Iran.
    Tahani B; Razavi SM; Emami H; Alamchi F
    Oral Maxillofac Surg; 2017 Dec; 21(4):429-437. PubMed ID: 28948377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the Diagnostic Accuracy of Baseline Clinical Examination and Ultrasonographic Imaging for the Detection of Lymph Node Metastasis in Patients With High-risk Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Tokez S; Koekelkoren FHJ; Baatenburg de Jong RJ; Grünhagen DJ; Mooyaart AL; Nijsten T; van der Lugt A; Wakkee M
    JAMA Dermatol; 2022 Feb; 158(2):151-159. PubMed ID: 34964807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up.
    Imbimbo M; Alfieri S; Botta L; Bergamini C; Gloghini A; Calareso G; Orlandi E; Iacovelli NA; Guzzo M; Granata R; Resteghini C; Locati L; Volpi CC; Licitra L; Bossi P
    Otolaryngol Head Neck Surg; 2019 Oct; 161(4):635-642. PubMed ID: 31286827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
    Kao J; Vu HL; Genden EM; Mocherla B; Park EE; Packer S; Som PM; Kostakoglu L
    Cancer; 2009 Oct; 115(19):4586-94. PubMed ID: 19544537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.